Indication:

1. For symptomatic improvement and healing of gastrointestinal diseases which require a reduction in acid secretion: i) Duodenal ulcer; ii) Gastric ulcer; iii) Gastro-oesophageal reflux disease (GORD): Symptomatic GORD. The treatment of heartburn and other symptoms associated with GORD; Reflux oesophagitis; iv) Gastrointestinal lesions refractory H2 blockers; v) Zollinger-Ellison Syndrome. Patients whose gastric or duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (NSAIDs) require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence. 2. Maintenance of healed reflux oesophagitis in patients previously treated for moderate to severe reflux oesophagitis. 3. Prevention of gastroduodenal lesions and dyspeptic symptoms associated with non-selective non-steroidal anti-inflammatory drugs (NSAIDs) in increased risk patients with a need for continuous non-selective NSAID treatment.

Generic Name: Pantoprazole

Strength: 40mg

Dosage: Tabs

Shelflife Months: 24

Pack Size: 30

Tablet Description: Yellow to pale yellow coloured oval, biconvex enteric coated tablets plain on both sides.

Segment :C

Innovator: Somac®

PBSListed: Yes

RPBSlisted: No

Schedule: S4

Storage Conditions: Store below 25 degrees Celsius

Active Ingredients: pantoprazole sodium sesquihydrate 45.4mg
Equivalent: pantoprazole 40mg

Warnings: